Donaldson Capital Management, LLC Edwards Lifesciences Corp Transaction History

Donaldson Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $54,841 - $81,323	-634 Reduced 13.22%	4,162 $396,000
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $158,241 - $199,183	-1,552 Reduced 24.45%	4,796 $565,000
Q4 2021 Jan 21, 2022	SELL	$106.37 - $130.68 $9,573 - $11,761	-90 Reduced 1.4%	6,348 $822,000
Q3 2021 Nov 04, 2021	SELL	$102.91 - $122.75 $2,675 - $3,191	-26 Reduced 0.4%	6,438 $729,000
Q2 2021 Jul 28, 2021	SELL	$83.84 - $104.76 $56,843 - $71,027	-678 Reduced 9.49%	6,464 $669,000
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $1,494 - $1,722	-19 Reduced 0.27%	7,142 $597,000
Q4 2020 Jan 11, 2021	SELL	$71.69 - $91.23 $122,016 - $155,273	-1,702 Reduced 19.2%	7,161 $653,000
Q3 2020 Nov 02, 2020	BUY	$67.19 - $87.44 $595,504 - $774,980	8,863 New	8,863 $707,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Donaldson Capital Management, LLC with notifications on news.